Ocugen-BBIL, COVID-19 Vaccine (Covaxin), Co-development, Supply & Commercialization Agreement – GHIAA

Ocugen-BBIL, COVID-19 Vaccine (Covaxin), Co-development, Supply & Commercialization Agreement

Contact Us

Get In Touch

comms@ghiaa.org

Tel: 919-419-0300
919-906-4818
Fax: 919-419-8833

Attn: Executive Director
GHIAA
PO Box 14713
Research Triangle Park, NC 27709, USA

Browse

Home
MAPGuide
About GHIAA
Team
News

Contact Us

Get In Touch

comms@ghiaa.org

Tel: 919-419-0300
919-906-4818
Fax: 919-419-8833

Attn: Executive Director
GHIAA
PO Box 14713
Research Triangle Park, NC 27709, USA

Browse

Home
MAPGuide
About GHIAA
Team
News

comms@ghiaa.org

© 2023 Global Healthcare Innovation Alliance Accelerator. All Rights Reserved